IO Biotech
FranceWho owns IO Biotech?
IO Biotech is a French Biotech company, currently owned by Eurazeo since 2019.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Held by Eurazeo since 2019 (7Y hold).
- ·Average hold across 2 realized cycles: 6 years.
Ownership history
3 ownership periods · co-invest detected
Lundbeckfonden BioCapital took IO Biotech public via IPO in 2021 after 6 years.
Sunstone Life Science Ventures took IO Biotech public via IPO in 2021 after 6 years.
More from Kurma Biofund III
Other portfolio companies in the same fund.
Netherlands
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns IO Biotech?
IO Biotech is currently owned by Eurazeo, through Kurma Biofund III, since 2019.
When did Eurazeo acquire IO Biotech?
Eurazeo acquired IO Biotech in 2019.
Who has owned IO Biotech over time?
IO Biotech has been through 3 private-equity ownership periods: Lundbeckfonden BioCapital · via Lundbeckfonden BioCapital · 2015–2021 · (IPO); Sunstone Life Science Ventures · via Sunstone Life Science Ventures IV · 2015–2021 · (IPO); Eurazeo · via Kurma Biofund III · since 2019.